Response of scalp psoriasis to oral ketoconazole.
P M Farr,
L B Krause,
J M Marks,
S Shuster
RCT
Lancet (London, England)
1985
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'pmid\u003D2865422';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Abstract
A randomised double-blind placebo-controlled study showed improvement of scalp psoriasis with oral ketoconazole, although the study had to be stopped before completion because of the possibility of drug toxicity. The common appearance of psoriasis in the scalp and certain other sites may be due to pityrosporal colonisation that also causes seborrhoeic dermatitis and dandruff.
Used In Evidence Reviews
Similar Papers
Skin therapy letter · 2012
Promising therapies for treating and/or preventing androgenic alopecia.
100 citations
The Journal of dermatology · 2002
Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
96 citations
Open Access
The Journal of dermatological treatment · 2019
Topical ketoconazole: a systematic review of current dermatological applications and future developments.
73 citations
The Journal of dermatology · 2018
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
69 citations
Open Access
International journal of cosmetic science · 2002
Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations.
53 citations
Open Access
Journal of dermatological science · 2007
Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity.
39 citations